Mohamed_Salama.jpg

Mohamed Salama, MD, PhD, DTQM

Atlantic Fellow at GBHI
TRINITY COLLEGE DUBLIN

mohamed.salama@gbhi.org
Home Country: Egypt
Field of Employment: Neurotoxicologist

Before joining GBHI Mohamed Salama was working on bridging the gap between basic research and clinical applications in neurodegenerative disorders. This involves studying the interplay between environment and genes in developing neurodegeneration e.g. Alzheimer's disease and Parkinson's disease.

Mohamed is from Egypt and believes that risk factors for dementia are still understudied in Egypt.

I believe dementia is a multidisciplinary problem, hence, it needs a multidisciplinary approach to solve it. It is not just a medical or research issue, it involves all aspects of life. This means we need to have people of different backgrounds brainstorming to find new innovative solutions and to improve the quality of life for patients. Currently, I am trying to cross the gap between different specialties in the Middle East region through the initiation of the Egyptian Network for Neurodegenerative Disorders. This network involves colleagues from different professional backgrounds who are trying to unravel the causes and risk factors for these disorders. I hope my fellowship at GBHI will help me to strengthen this network and build new partners. I am also looking forward to exploring Dublin, making new friends and exploring new areas.

Bio: Mohamed Salama obtained his Medical Degree in 1999 from Mansoura University, Egypt where he began his clinical training. He then started his post as clinical toxicologist at Mansoura University Poison Control Center. He received his MSc in Toxicology in 2006, and through a DAAD scholarship his PhD degree in Neurotoxicology in 2011 through collaboration with Philipps University in Marburg, Germany. Upon returning to Egypt he realized that there was a large gap between basic neuroscience research and clinical application. He established the first Translational Neuroscience Unit in Egypt. Mohamed’s collaborative research led to establishing the Egyptian Network for Neurodegenerative Disorders (ENND: www.enndeg.com). Mohamed was selected as an SOT Global Senior Scholar in 2013 and Translational/bridging awardee on 2016. He was awarded by Parkinson’s and Movement Disorders Foundation (PMDF) for his continuing research in the field of neurodegeneration. Recently he was selected as a member of the Egyptian Young Academy of Science (EYAS). Currently, Mohamed is the director of the Medical Experimental Research Center (MERC) of Mansoura University.

PDF